Research shows that continuing GLP-1 therapy helps sustain weight loss and reduces the risk of regaining weight
Obesity is a known risk factor for reduced testosterone in men, primarily due to the increased conversion of testosterone to estrogen in adipose tissue and the insulin resistance associated with obesity, which can impair hormonal regulation
Write down when your hot flashes happen, how long they last, and any other symptoms you experience
Thats especially true after a major transformation, like losing 30+ pounds or completing a semaglutide-based weight loss program
Every entry above reflects component-level preclinical research, not a KLOW-blend human trial
In fact, the GLP-1 market was valued at $16.53 billion in 2021 and is expected to reach a whopping $24.10 billion by 2027